Newsroom

#artificialintelligence 

Nashua, N.H. – September 10, 2019 – iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced the results of its reader study for ProFound AI fo... Continue reading